Portolan Capital Management, LLC Royalty Pharma PLC Transaction History
Portolan Capital Management, LLC
- $1.32 Billion
- Q4 2024
A detailed history of Portolan Capital Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Portolan Capital Management, LLC holds 344,185 shares of RPRX stock, worth $11.5 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
344,185
Previous 170,464
101.91%
Holding current value
$11.5 Million
Previous $4.82 Million
82.08%
% of portfolio
0.66%
Previous 0.38%
Shares
7 transactions
Others Institutions Holding RPRX
# of Institutions
429Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.32 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$769 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$567 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$472 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...